GoHealth, Inc. (NASDAQ:GOCO - Get Free Report) was the recipient of a large decline in short interest in December. As of December 31st, there was short interest totalling 129,400 shares, a decline of 8.7% from the December 15th total of 141,700 shares. Approximately 1.6% of the company's shares are sold short. Based on an average daily volume of 38,900 shares, the short-interest ratio is presently 3.3 days.
Wall Street Analyst Weigh In
Separately, Royal Bank of Canada reiterated a "sector perform" rating and set a $13.00 price target on shares of GoHealth in a report on Monday, October 21st.
Check Out Our Latest Analysis on GOCO
GoHealth Stock Up 1.6 %
Shares of GOCO traded up $0.22 during trading hours on Friday, reaching $13.74. The company's stock had a trading volume of 43,741 shares, compared to its average volume of 53,081. The company has a 50 day moving average of $12.58 and a two-hundred day moving average of $11.07. The company has a quick ratio of 1.18, a current ratio of 1.18 and a debt-to-equity ratio of 1.72. The firm has a market cap of $314.78 million, a price-to-earnings ratio of -3.93 and a beta of 1.64. GoHealth has a 1-year low of $7.27 and a 1-year high of $14.99.
Institutional Inflows and Outflows
A number of institutional investors and hedge funds have recently added to or reduced their stakes in GOCO. Bank of New York Mellon Corp boosted its stake in shares of GoHealth by 16.1% during the 2nd quarter. Bank of New York Mellon Corp now owns 12,982 shares of the company's stock valued at $126,000 after buying an additional 1,802 shares during the period. Renaissance Technologies LLC raised its holdings in shares of GoHealth by 22.0% during the second quarter. Renaissance Technologies LLC now owns 18,272 shares of the company's stock worth $178,000 after acquiring an additional 3,300 shares in the last quarter. Empowered Funds LLC boosted its position in GoHealth by 5.1% during the third quarter. Empowered Funds LLC now owns 22,048 shares of the company's stock valued at $207,000 after purchasing an additional 1,072 shares during the last quarter. Barclays PLC grew its stake in GoHealth by 83.9% in the third quarter. Barclays PLC now owns 9,580 shares of the company's stock valued at $89,000 after purchasing an additional 4,372 shares in the last quarter. Finally, Geode Capital Management LLC increased its position in GoHealth by 3.2% in the 3rd quarter. Geode Capital Management LLC now owns 103,735 shares of the company's stock worth $973,000 after purchasing an additional 3,205 shares during the last quarter. 24.21% of the stock is owned by hedge funds and other institutional investors.
GoHealth Company Profile
(
Get Free Report)
GoHealth, Inc operates as a health insurance marketplace and Medicare-focused digital health company in the United States. The company operates a technology platform that leverages machine-learning algorithms of insurance behavioral data to optimize the process for helping individuals find the health insurance plan for their specific needs.
Further Reading
Before you consider GoHealth, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and GoHealth wasn't on the list.
While GoHealth currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Unlock the timeless value of gold with our exclusive 2025 Gold Forecasting Report. Explore why gold remains the ultimate investment for safeguarding wealth against inflation, economic shifts, and global uncertainties. Whether you're planning for future generations or seeking a reliable asset in turbulent times, this report is your essential guide to making informed decisions.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.